Stanford University School of Medicine is the medical school of Stanford University and is located in Stanford, California. It traces its roots to the Medical Department of the University of the Pacific, founded in San Francisco in 1858.

During the past decade, Stanford University School of Medicine conducted 17 clinical trials. In the 10-year time frame, 17 clinical trials started and 7 clinical trials were completed, i.e. on average, 41.2% percent of trials that started reached the finish line to date. In the past 5 years, 11 clinical trials started and 4 clinical trials were completed. i.e. 36.4% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Stanford University School of Medicine" #1 sponsor was "Stanford University" with 4 trials, followed by "Takeda" with 3 trials sponsored, "Janssen Research & Development, LLC" with 2 trials sponsored, "Millennium Pharmaceuticals, Inc." with 2 trials sponsored and "Acrotech Biopharma Inc." with 2 trials sponsored. Other sponsors include 3 different institutions and companies that sponsored additional 13 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Stanford University School of Medicine" #1 collaborator was "Neurofit Inc, Mountain View, California" with 2 trials as a collaborator, "Bold Health Inc." with 1 trials as a collaborator and "Takeda Development Center Americas, Inc." with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Stanford University School of Medicine" are "Alopecia Areata" (1 trials), "Bariatric Surgery Candidate" (1 trials), "Cirrhosis" (1 trials), "Crohn's Disease" (1 trials) and "Cutaneous T-cell Lymphoma" (1 trials). Many other conditions were trialed in "Stanford University School of Medicine" in a lesser frequency.

Most popular intervention types in "Stanford University School of Medicine" are "Drug" (13 trials), "Device" (5 trials), "Biological" (2 trials), "Dietary Supplement" (2 trials) and "Diagnostic Test" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (9 trials), "TAK-925" (2 trials), "TAK-994" (2 trials), "Accelerometry" (1 trials) and "Apremilast 10mg" (1 trials). Other intervention names were less common.

The vast majority of trials in "Stanford University School of Medicine" are 20 trials for "All" genders.

Currently, there are NaN active trials in "Stanford University School of Medicine". undefined are not yet recruiting, 3 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 11 completed trials in Stanford University School of Medicine, undefined suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in Stanford University School of Medicine, 3 "Phase 1" clinical trials were conducted, 10 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 3 trials that are defined as “Not Applicable".